- Home
- WOLF vs PRME Comparison
WOLF vs PRME Comparison
Compare WOLF & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- PRME
- Stock Information
- Founded
- WOLF 1987
- PRME 2019
- Country
- WOLF United States
- PRME United States
- Employees
- WOLF N/A
- PRME N/A
- Industry
- WOLF Semiconductors
- PRME Medicinal Chemicals and Botanical Products
- Sector
- WOLF Technology
- PRME Health Care
- Exchange
- WOLF Nasdaq
- PRME Nasdaq
- Market Cap
- WOLF 200.8M
- PRME 191.7M
- IPO Year
- WOLF 1993
- PRME 2022
- Fundamental
- Price
- WOLF $1.46
- PRME $4.27
- Analyst Decision
- WOLF Hold
- PRME Buy
- Analyst Count
- WOLF 14
- PRME 6
- Target Price
- WOLF $10.67
- PRME $9.38
- AVG Volume (30 Days)
- WOLF 216.3M
- PRME 5.1M
- Earning Date
- WOLF 08-20-2025
- PRME 08-04-2025
- Dividend Yield
- WOLF N/A
- PRME N/A
- EPS Growth
- WOLF N/A
- PRME N/A
- EPS
- WOLF N/A
- PRME N/A
- Revenue
- WOLF $761,300,000.00
- PRME $3,846,000.00
- Revenue This Year
- WOLF N/A
- PRME $104.12
- Revenue Next Year
- WOLF $11.97
- PRME $108.24
- P/E Ratio
- WOLF N/A
- PRME N/A
- Revenue Growth
- WOLF N/A
- PRME 550.76
- 52 Week Low
- WOLF $0.39
- PRME $1.11
- 52 Week High
- WOLF $3.33
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- WOLF 52.05
- PRME 80.29
- Support Level
- WOLF $0.55
- PRME $2.28
- Resistance Level
- WOLF $3.33
- PRME $4.83
- Average True Range (ATR)
- WOLF 0.39
- PRME 0.46
- MACD
- WOLF 0.22
- PRME 0.21
- Stochastic Oscillator
- WOLF 41.33
- PRME 84.52
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.